human
norovirus
hunov
major
caus
viral
gastroenter
worldwid
estim
million
case
year
unit
kingdom
alon
hunov
member
calicivirida
famili
singlestrand
positivesens
rna
genom
caus
varieti
diseas
manifest
wide
rang
speci
noroviru
genu
divid
least
six
differ
genogroup
base
capsid
sequenc
hunov
strain
fall
genogroup
ii
iv
gi
gii
giv
gii
strain
respons
hunov
case
worldwid
genotyp
preval
overal
human
hunov
typic
caus
acut
diarrhea
vomit
abdomin
cramp
ill
last
averag
h
infect
common
health
care
institut
hospit
longtermcar
facil
outbreak
often
report
associ
school
restaur
cruis
ship
set
militari
base
transmiss
hunov
via
contact
fece
vomit
occur
predominantli
direct
persontoperson
contact
contamin
food
water
zoonot
transmiss
hunov
also
propos
hypothet
rout
infect
cattl
pig
come
scrutini
potenti
role
transmit
hunov
past
decad
precipit
identif
hunov
rna
stool
farm
pig
cattl
furthermor
half
pig
us
report
seroposit
gi
gii
human
norovirus
find
support
studi
demonstr
human
strain
replic
induc
immun
respons
gnotobiot
pig
dog
first
suggest
potenti
zoonot
vector
hunov
follow
outbreak
noroviru
gastroenter
elderlycar
home
prior
develop
clinic
symptom
human
owner
dog
sick
multipl
occas
around
home
serolog
test
dog
later
reveal
moder
titer
hunov
antigen
electron
microscopi
wherea
control
dog
seroneg
later
evid
link
dog
hunov
infect
human
follow
epidemiolog
studi
show
seroposit
hunov
human
higher
dog
household
antihunov
antibodi
recent
identifi
dog
across
europ
report
hunov
could
detect
stool
sampl
pet
dog
sampl
collect
dog
dog
owner
recent
suffer
diarrhea
vomit
canin
stool
sampl
test
presenc
gi
gii
giv
hunov
dog
found
posit
gii
hunov
one
case
hunov
strain
identifi
ident
isol
stool
owner
presenc
ident
sequenc
formal
confirm
activ
replic
dog
level
viral
rna
observ
would
suggest
least
limit
replic
occur
primari
step
hunov
infect
cell
requir
hunov
bind
complex
carbohydr
known
histoblood
group
antigen
hbga
well
express
erythrocyt
hbga
express
surfac
epitheli
cell
gastrointestin
genitourinari
respiratori
tract
secret
cell
bodili
fluid
includ
saliva
intern
viral
particl
cell
occur
follow
hunov
attach
hbga
vitro
therefor
propos
primari
step
hunov
uptak
cell
hunov
bind
hbga
import
hbga
bind
human
infect
demonstr
experiment
challeng
studi
shown
suscept
hunov
infect
relat
express
hbga
gastrointestin
tract
approxim
caucasian
express
gastrointestin
hbga
due
lack
function
fucosyltransferas
gene
nonsecretor
consequ
individu
significantli
reduc
suscept
infect
norovirus
dog
suscept
human
noroviru
reason
dog
must
express
hbga
gastrointestin
tract
although
canin
blood
type
bear
resembl
human
system
inde
canin
erythrocyt
agglutin
hunov
recent
demonstr
dog
express
hbga
saliva
surfac
intestin
epitheli
cell
indic
dog
express
relev
attach
factor
primari
step
hunov
infect
indic
theoret
suscept
hunov
approxim
million
dog
unit
kingdom
divid
among
household
suggest
hunov
may
transmiss
speci
consider
public
health
concern
studi
aim
investig
abil
hunov
infect
dog
frequenc
might
occur
unit
kingdom
achiev
first
explor
relationship
canin
hbga
express
hunov
bind
canin
tissu
second
determin
occurr
current
past
hunov
infect
dog
use
hunov
rna
survey
canin
stool
sampl
serolog
survey
canin
serum
collect
canin
saliva
sampl
nonregul
procedur
henc
ethic
approv
requir
similarli
ethic
approv
requir
collect
canin
stool
serum
sampl
either
anim
wast
product
surplu
diagnost
requir
deriv
previous
publish
ethic
approv
studi
canin
gastrointestin
tissu
sampl
donat
larg
pharmaceut
compani
six
dog
bred
scientif
research
deem
unsuit
purpos
human
euthan
human
saliva
sampl
collect
part
previou
studi
approv
nant
univers
hospit
review
board
studi
inform
written
consent
obtain
saliva
donor
stool
sampl
collect
dog
admit
six
particip
unit
kingdom
veterinari
clinic
suffolk
kent
lincolnshir
middlesex
cambridgeshir
dog
recruit
studi
pass
stool
hospit
owner
consent
stool
collect
veterinari
personnel
addit
sampl
collect
wood
green
anim
shelter
cambridgeshir
unit
kingdom
dog
suspect
infecti
gastroenter
stool
sampl
store
transport
laboratori
whereaft
store
prior
extract
rna
control
stool
sampl
nonveterinari
patient
collect
healthi
dog
own
veterinari
staff
well
dog
particip
board
kennel
basic
case
data
record
dog
stool
sampl
collect
includ
age
breed
sex
reason
admiss
recent
histori
enter
diseas
canin
serum
sampl
obtain
two
separ
dog
popul
sampl
collect
rehom
kennel
part
exist
studi
serum
sampl
surplu
diagnost
requir
obtain
veterinari
patient
royal
veterinari
colleg
london
blood
collect
biochem
analysi
diagnost
purpos
canin
saliva
sampl
collect
dog
wood
green
anim
shelter
huntingdon
unit
kingdom
number
sampl
collect
three
dog
pharmacolog
research
compani
unit
kingdom
label
e
f
dog
anim
shelter
mix
breed
wherea
research
dog
beagl
sampl
collect
achiev
use
children
swab
salimetr
newmarket
unit
kingdom
saliva
extract
human
saliva
sampl
collect
part
previou
studi
canin
tissu
sampl
donat
six
healthi
femal
dog
label
f
human
euthan
surplu
industri
research
requir
section
gastrointestin
tract
dissect
previous
describ
briefli
either
sampl
duodenum
jejunum
ileum
cecum
colon
fix
embed
paraffin
section
section
lyse
homogen
gener
scrape
sampl
stool
dilut
wtvol
phosphatebuff
salin
pb
ph
solid
remov
centrifug
g
min
viral
nucleic
acid
extract
clarifi
stool
suspens
genelut
mammalian
total
rna
miniprep
kit
sigmaaldrich
accord
manufactur
instruct
intern
extract
control
ad
sampl
nucleic
acid
extract
verifi
remov
pcr
inhibitor
enabl
precis
quantif
viral
nucleic
acid
fix
amount
equin
arter
viru
eav
rna
ad
lysi
buffer
sampl
obtain
eav
concentr
approxim
copi
per
ml
fecal
suspens
qrtpcr
use
screen
genogroup
gi
genogroup
gii
hunov
use
previous
publish
primerprob
set
sampl
also
screen
caninespecif
norovirus
use
primerprob
set
design
identifi
six
differ
strain
canin
noroviru
cnv
tabl
well
canin
parvoviru
cpv
canin
enter
coronaviru
cecov
duplex
assay
previous
report
use
qrtpcr
protocol
extract
rna
ad
precis
onestep
qrtpcr
mastermix
primerdesign
ltd
primer
probe
thermal
cycl
protocol
use
qpcr
machin
ab
appli
biosystem
follow
min
inactiv
revers
transcriptas
min
cycl
consist
denatur
anneal
elong
min
viruslik
particl
vlp
seven
differ
hunov
genotyp
vlp
three
strain
cnv
produc
use
previous
describ
method
access
number
hunov
strain
use
gener
vlp
studi
list
tabl
recombin
baculovirus
contain
human
canin
noroviru
protein
gener
vlp
produc
infect
insect
cell
vlp
releas
infect
cell
freezethaw
clarifi
remov
cellular
debri
g
min
baculoviru
g
min
vlp
partial
purifi
wtvol
sucros
cushion
tnc
buffer
mm
tri
hcl
ph
mm
nacl
mm
contain
proteas
inhibitor
leupeptin
g
h
pellet
vlp
resuspend
tnc
purifi
isopycn
centrifug
cesium
chlorid
g
h
result
vlp
band
collect
punctur
solut
contain
vlp
dialyz
pb
prior
quantif
bicinchonin
acid
bca
protein
assay
thermo
scientif
storag
vlp
visual
electron
microscopi
confirm
correct
particl
assembl
fig
vlp
studi
made
use
ident
protocol
form
defin
band
cesium
chlorid
gradient
deem
suffici
confirm
vlp
format
genotyp
ninetysixwel
polystyren
microtit
plate
nunc
maxisorb
fisher
scientif
coat
overnight
ng
gi
strain
strain
total
ngwell
gii
strain
strain
total
ngwell
carbonatebicarbon
buffer
ph
plate
wash
three
time
tween
phosphatebuff
salin
pbst
block
skim
h
three
pbst
wash
plate
incub
h
dilut
serum
sampl
duplic
skim
pool
human
sera
sigmaaldrich
dilut
ng
pool
gii
human
noroviru
vlp
use
posit
control
three
wash
pbst
horseradish
peroxidas
hrp
conjug
anticanin
antihuman
igg
antibodi
sigmaaldrich
dilut
respect
ad
well
incub
h
plate
wash
three
time
pbst
bound
antibodi
detect
tetramethylbenzidin
tmb
sigmaaldrich
follow
incub
room
temperatur
min
reaction
stop
n
optic
densiti
nm
read
spectromax
plate
reader
molecular
devic
elimin
possibl
nonspecif
compon
vlp
prepar
identifi
canin
sera
antigen
distinct
vesiviru
vlp
includ
assay
serum
sampl
incub
either
carbonatebicarbon
bufferco
well
vesiviru
well
highli
compar
except
dog
display
reactiv
vesiviru
limit
methodolog
data
shown
suspect
reactiv
vesiviru
could
due
crossreact
relat
canin
caliciviru
correl
seroposit
hunov
seroposit
vesiviru
shown
see
fig
supplement
materi
subsequ
background
signal
sampl
determin
measur
serum
sampl
incub
carbonatebicarbon
buffer
alon
background
signal
subtract
vlpcoat
well
gener
correct
valu
threshold
valu
establish
mean
bufferco
cell
plu
standard
deviat
serum
sampl
consid
posit
correct
higher
threshold
serum
sampl
show
posit
respons
pool
hunov
vlp
subject
test
individu
hunov
vlp
plate
coat
ng
individu
vlp
carbonatebicarbon
buffer
protocol
repeat
describ
evalu
serolog
crossreact
differ
noroviru
strain
achiev
use
vlp
competit
assay
antibodi
competit
assay
vlp
competit
assay
plate
first
coat
ngwell
vlp
overnight
canin
serum
incub
rang
concentr
either
pool
gi
gii
hunov
vlp
pool
cnv
vlp
h
vesiviru
vlp
incub
canin
sera
neg
control
incub
period
serumvlp
combin
ad
previous
vlpcoat
plate
remaind
elisa
protocol
follow
detail
concentr
vlp
requir
block
bind
effect
concentr
calcul
fit
sigmoid
curv
serial
dilut
data
sampl
unabl
block
bind
highest
dilut
test
assign
assay
upper
limit
detect
antibodi
competit
assay
polyclon
antinoroviru
vlp
antibodi
gener
immun
rabbit
hunov
rat
cnv
previous
describ
plate
coat
ngwell
vlp
overnight
block
h
skim
rabbit
rat
anticnv
antibodi
ad
well
serial
dilut
skim
h
follow
three
wash
pbst
canin
serum
ad
remaind
elisa
protocol
follow
describ
assay
assess
vlp
bind
saliva
gastrointestin
scrape
use
elisa
protocol
describ
addit
ng
hunov
vlp
per
well
skim
block
step
skim
vlp
incub
h
saliva
gastrointestin
scrape
sampl
detect
use
polyclon
rabbit
rabbit
primari
antibodi
goat
hrpconjug
antirabbit
antibodi
interchim
franc
use
secondari
antibodi
previous
describ
saliva
phenotyp
assay
use
elisa
protocol
detail
variat
describ
previou
studi
vlp
heat
min
presenc
sd
load
buffer
electrophores
sdspolyacrylamid
gel
coomassi
blue
stain
gel
incub
coomassi
blue
h
room
temperatur
prior
destain
protein
transfer
sdspolyacrylamid
gel
polyvinyliden
difluorid
membran
western
blot
membran
block
h
room
temperatur
milk
pbst
incub
overnight
canin
serum
sampl
dilut
excess
antibodi
wash
three
time
pbst
incub
h
anticanin
igg
secondari
antibodi
conjug
horseradish
peroxidas
sigmaaldrich
dilut
wash
away
excess
secondari
antibodi
band
detect
use
enhanc
chemiluminesc
reagent
ge
healthcar
tissu
section
gastrointestin
tract
six
dog
deparaffin
bath
lmrsol
acetonitril
follow
rehydr
success
bath
ethanol
endogen
peroxidas
activ
block
hydrogen
peroxid
pb
nonspecif
bind
block
bovin
serum
albumin
bsa
pb
h
antigen
detect
perform
previous
report
assess
abil
vlp
bind
tissu
section
block
vlp
incub
section
overnight
room
temperatur
antihunov
primari
antibodi
incub
tissu
section
h
three
wash
pb
section
incub
secondari
antirabbit
biotinyl
antibodi
vector
laboratori
burlingam
ca
dilut
bsa
pb
h
section
wash
three
time
pb
prior
addit
hrpconjug
avidin
vector
laboratori
burlingam
ca
also
dilut
bsa
pb
substrat
ad
slide
aec
kit
vector
laboratori
burlingam
ca
follow
mayer
hematoxylin
solut
merck
whitehous
station
nj
contrast
stain
saliva
sampl
dog
f
duoden
scrape
dog
f
analyz
elisabas
assay
abil
bind
hunov
vlp
fig
canin
sampl
phenotyp
hbga
express
previou
studi
therefor
known
h
antigen
express
present
everi
canin
sampl
antigen
lewi
antigen
express
polymorph
human
saliva
sampl
repres
major
hbga
phenotyp
present
human
use
control
human
sampl
includ
saliva
nonsecretor
individu
hbga
express
saliva
human
express
either
antigen
b
antigen
h
antigen
alon
phenotyp
saliva
sampl
variat
lewi
antigen
express
also
includ
saliva
bind
assay
fig
nonsecretor
human
sampl
unabl
bind
hunov
vlp
expect
base
previou
report
contrast
canin
saliva
sampl
secretor
human
sampl
abl
bind
hunov
vlp
compar
valu
canin
human
saliva
sampl
indic
similar
level
bind
vlp
seven
differ
hunov
genotyp
use
assess
abil
bind
duoden
scrape
six
dog
f
fig
human
saliva
sampl
antigenposit
lewi
antigenposit
individu
antigenneg
lewi
antigenneg
individu
use
posit
control
sampl
shown
fig
bind
hunov
vlp
figur
demonstr
canin
duoden
scrape
could
bind
everi
hunov
genotyp
test
individu
variat
sampl
identifi
exampl
canin
sampl
e
f
show
decreas
bind
hunov
vlp
dog
howev
notabl
dog
b
c
abl
bind
hunov
vlp
test
appar
relat
hbga
phenotyp
dog
h
antigen
posit
dog
c
e
antigen
posit
wherea
dog
b
f
antigen
neg
previous
report
addit
dog
phenotyp
lewi
antigen
dog
b
lewi
posit
remaind
lewi
neg
data
shown
variat
scale
genotyp
arbitrari
due
primari
antibodi
use
detect
gi
vlp
primari
antibodi
use
rais
wherea
gii
vlp
primari
antibodi
rais
determin
whether
hunov
vlp
abl
bind
canin
gastrointestin
tissu
fix
section
duodenum
two
dog
b
c
incub
hunov
vlp
h
immunohistochemistri
ihc
use
detect
bind
hunov
vlp
tissu
surfac
polymorph
antigen
present
dog
approxim
antigen
posit
due
known
interact
antigen
hunov
hbga
phenotyp
also
requir
confirm
presenc
absenc
h
antigen
antigen
tissu
section
use
vlp
bind
achiev
incub
tissu
section
ulex
antia
antigen
antibodi
respect
ihc
perform
demonstr
dog
c
antigen
posit
dog
b
antigen
neg
henc
enabl
comparison
hunov
vlp
bind
canin
sampl
repres
two
major
hbga
phenotyp
h
antigen
express
detect
aposit
dog
understood
due
abil
antigen
mask
h
antigen
therefor
prevent
detect
ulex
lectin
bind
figur
demonstr
hunov
vlp
bind
antigenposit
antigenneg
dog
addit
shown
hunov
vlp
bind
pattern
express
similar
h
antigen
given
known
interact
hbga
hunov
similar
bind
pattern
expect
total
canin
stool
sampl
collect
analyz
presenc
hunov
rna
stool
sampl
clinic
data
collect
dog
admit
veterinari
clinic
rescu
kennel
distribut
across
unit
kingdom
august
may
mean
age
dog
year
standard
deviat
year
differ
breed
repres
total
sampl
dog
clinic
sign
primari
gastroenter
control
sampl
collect
healthi
dog
mean
age
year
standard
deviat
year
board
kennel
belong
veterinari
staff
nucleic
acid
extract
qpcr
success
perform
stool
sampl
determin
constant
threshold
cycl
ct
valu
intern
extract
control
rna
sampl
test
qpcr
presenc
hunov
cnv
sampl
identifi
posit
norovirus
indic
overal
preval
norovirus
popul
time
sampl
collect
wilson
binomi
approxim
confid
interv
confirm
efficaci
screen
method
sampl
also
test
presenc
two
addit
canin
virus
previous
report
present
unit
kingdom
canin
parvoviru
cpv
canin
enter
coronaviru
cecov
enter
virus
either
cpv
cecov
detect
high
titer
copiesml
stool
dog
admit
primari
gastroenter
virus
detect
titer
posit
threshold
assay
dog
without
gastroenter
seven
genotyp
hunov
vlp
use
elisa
screen
antihunov
antibodi
total
dog
serum
sampl
collect
two
group
dog
ie
sampl
collect
cohort
sampl
collect
cohort
b
three
gi
hunov
vlp
pool
preliminari
assay
four
gii
vlp
primari
antihunov
antibodi
screen
identifi
antihunov
antibodi
detect
level
sera
dog
cohort
cohort
b
tabl
dog
seroposit
gi
gii
hunov
wherea
remaind
seroposit
either
gi
gii
hunov
seroposit
cnv
canin
serum
sampl
previous
report
data
ad
tabl
comparison
age
dog
time
sampl
known
dog
cohort
b
relationship
seroposit
hunov
age
identifi
data
shown
estim
magnitud
canin
antihunov
antibodi
respons
antihunov
titer
determin
sampl
seroposit
gi
hunov
sampl
seroposit
gii
hunov
present
tabl
antibodi
titer
gi
dog
seroposit
primari
elisa
screen
rel
low
valu
obtain
titer
elisa
show
strong
consist
comparison
origin
elisa
screen
major
antigii
hunovposit
serum
sampl
similarli
low
antibodi
titer
mode
determin
contrast
case
gi
three
sampl
giiseroposit
sampl
test
antibodi
titer
higher
extend
find
preliminari
elisa
canin
serum
sampl
posit
hunov
enter
second
round
elisa
individu
genotyp
hunov
investig
whether
possibl
identifi
hunov
genotyp
may
elicit
antihunov
immun
respons
acknowledg
immunolog
crossreact
exist
noroviru
genotyp
thu
conclus
identif
primari
genotyp
induc
antibodi
product
aim
experi
howev
genotyp
highest
valu
induc
elisa
tent
suggest
major
hunov
genotyp
involv
exampl
serum
sampl
highest
hunov
vlp
design
specif
purpos
studi
figur
present
genotyp
distribut
hunov
giiposit
sampl
compar
cohort
cohort
b
data
show
antibodi
common
cohort
although
wherea
sampl
show
highest
cohort
figur
increas
cohort
b
confirm
antihunov
antibodi
identifi
dog
mere
result
crossreact
caninespecif
norovirus
seri
block
assay
perform
fig
highlight
tabl
previous
shown
seropreval
cnv
high
popul
dog
analyz
studi
first
necessari
establish
cnvspecif
antibodi
crossreact
hunov
achiev
preincub
variou
concentr
hunov
cnv
vlp
repres
anticnv
antibodyposit
canin
serum
serum
analyz
abil
serum
detect
cnv
vlp
fig
preincub
cnv
vlp
clearli
abl
block
recognit
cnv
vlp
canin
serum
wherea
preincub
gi
gii
vlp
effect
cnv
vlp
recognit
confirm
epitop
recogn
anticnv
antibodi
distinct
epitop
present
hunov
vlp
next
specif
antigii
antibodi
identifi
canin
sera
examin
use
similar
vlp
competit
assay
gii
vlp
appli
microtit
plate
instead
cnv
vlp
fig
concentr
hunov
cnv
vlp
requir
block
bind
gii
vlp
calcul
fit
sigmoid
curv
valu
serial
dilut
vlp
seven
differ
canin
serum
sampl
vii
identifi
posit
antigii
antibodi
analyz
serum
neg
gii
bind
ad
neg
control
sampl
vii
type
vlp
induc
lowest
block
gii
vlp
recognit
canin
serum
gii
hunov
vlp
cnv
vlp
induc
decreas
gii
recognit
upper
threshold
detect
case
greater
concentr
cnv
vlp
gii
vlp
requir
suggest
degre
crossreact
gii
hunov
cnv
like
differenti
possibl
final
block
assay
conduct
investig
specif
antibodi
detect
canin
serum
use
antibodi
gener
anim
immun
sole
either
cnv
gii
hunov
vlp
fig
anim
rat
rabbit
respect
would
expos
natur
infect
henc
antibodi
serum
deem
specif
vlp
immunogen
anticnv
antigii
hunov
serum
serial
dilut
incub
directli
gii
vlp
appli
microtit
plate
plate
wash
giiposit
canin
serum
serum
vi
incub
follow
result
show
rat
cnvspecif
antiserum
unabl
block
recognit
gii
hunov
canin
serum
wherea
rabbit
giispecif
antiserum
induc
block
gii
vlp
recognit
canin
serum
western
blot
use
altern
method
demonstr
presenc
antihunov
antibodi
canin
sera
five
serum
sampl
identifi
posit
antihunov
antibodi
elisa
select
use
western
blot
fig
singl
serum
sampl
sampl
shown
neg
human
canin
norovirus
select
neg
control
western
blot
confirm
canin
sera
five
repres
sampl
could
detect
vlp
express
independ
recognit
genogroup
iv
vi
cnv
studi
sought
investig
likelihood
dog
infect
hunov
follow
initi
report
hunov
detect
stool
dog
result
serolog
survey
vlp
bind
studi
strongli
suggest
dog
suscept
hunov
howev
frequenc
occur
deem
low
base
epidemiolog
result
report
furthermor
clinic
implic
dog
peopl
contact
dog
still
remain
confirm
human
shown
hunov
bind
cell
surfac
carbohydr
hbga
famili
prior
intern
hbga
express
epitheli
cell
mani
speci
recent
confirm
includ
dog
find
led
us
hypothes
hunov
would
abl
bind
gastrointestin
tract
dog
elisa
ihc
data
present
report
abl
confirm
demonstr
initi
step
requir
hunov
entri
canin
cell
present
howev
note
rabbit
hemorrhag
diseas
viru
rdhv
relat
distinct
member
calicivirida
famili
bind
hbga
h
type
antigen
b
antigen
yet
evid
rhdv
infect
speci
wild
domest
rabbit
oryctolagu
cuniculu
speci
hbga
bind
may
initi
step
calicivirushost
interact
subsequ
hostrestrict
step
must
necessari
rhdv
infect
potenti
hunov
infect
dog
viral
rna
survey
conduct
part
project
reveal
canin
stool
sampl
contain
hunov
rna
impli
incid
hunov
shed
popul
dog
neglig
despit
sampl
collect
healthi
dog
anim
dog
nongastroenter
diseas
anim
dog
sever
gastroenter
requir
veterinari
attent
anim
inclus
sampl
latter
two
group
essenti
suggest
hunov
may
like
infect
dog
underli
diseas
immunodefici
caninespecif
norovirus
associ
gastroenter
dog
hypothes
hunov
infect
dog
may
caus
sign
gastroenter
diseas
gastroenter
common
condit
dog
owner
questionnair
report
diarrhea
dog
within
previou
period
canin
veterinari
consult
address
gastroenter
primari
complaint
dog
gastroenter
survey
cpv
dog
cecov
dog
detect
prove
viral
gastroenter
rel
common
dog
norovirus
major
caus
viral
diseas
popul
dog
sampl
likelihood
hunov
infect
dog
result
clinic
sign
gastroenter
clearli
much
lower
cpv
cecov
infect
immedi
caus
concern
owner
veterinarian
absenc
hunovposit
stool
sampl
dog
studi
contrast
result
summa
et
al
identifi
hunov
rna
canin
stool
sampl
howev
sampl
strategi
significantli
differ
approach
canin
stool
sampl
collect
owner
shown
symptom
gastroenter
within
past
week
wherea
stool
sampl
studi
collect
refer
recent
owner
ill
hunov
human
typic
acut
infect
peak
viral
shed
occur
day
infect
week
infect
case
still
posit
viral
rna
addit
although
hunov
respons
million
infect
worldwid
year
viru
identifi
approxim
human
diarrheic
sampl
submit
detect
hunov
rna
fece
limit
factor
low
viru
concentr
improp
storag
sampl
ineffici
viral
rna
extract
presenc
fecal
revers
transcriptas
inhibitor
overal
indic
posit
identif
hunov
shed
dog
possibl
within
narrow
time
frame
proport
case
fals
neg
suggest
order
confirm
hunov
shed
canin
stool
determin
accur
preval
rate
much
larger
sampl
size
andor
focus
sampl
approach
eg
collect
stool
sampl
owner
confirm
hunov
infect
requir
serolog
analysi
canin
serum
sampl
studi
strongli
suggest
dog
mount
immun
respons
hunov
demonstr
almost
dog
sampl
antibodi
could
recogn
hunov
vlp
suggest
dog
expos
hunov
unit
kingdom
proport
lower
proport
dog
report
seroposit
hunov
recent
survey
across
europ
may
reflect
popul
differ
import
conclus
studi
hunov
seropreval
rate
identifi
dog
substanti
lower
hunov
seroposit
among
human
popul
unit
kingdom
nearli
peopl
seroposit
indic
either
dog
expos
much
rare
hunov
much
less
suscept
infect
human
given
one
questionnairebas
studi
dog
slept
owner
hous
owner
home
almost
dog
allow
anywher
hous
seem
unlik
dog
would
expos
hunov
household
infect
human
therefor
propos
dog
suscept
hunov
much
lower
level
human
could
argu
antihunov
antibodi
identifi
canin
sera
may
gener
respons
infect
relat
nonhuman
norovirus
mere
crossreact
hunov
exampl
anticnv
antibodi
detect
serum
sampl
use
studi
investig
seri
block
assay
perform
use
canin
serum
sampl
serum
sampl
rat
inocul
cnv
vlp
abl
show
antigii
hunov
antibodi
specif
gii
hunov
vlp
three
differ
strain
cnv
giv
gvi
acknowledg
nonhuman
noncanin
norovirus
dog
may
expos
exampl
swine
bovin
felin
norovirus
crossreact
assess
howev
crossreact
genogroup
known
limit
thu
antibodi
specif
felin
norovirus
genotyp
certain
canin
norovirus
bovin
norovirus
giii
highli
unlik
crossreact
gii
human
norovirus
swine
norovirus
howev
classifi
gii
alongsid
human
strain
thu
greater
risk
crossreact
nevertheless
due
unit
kingdom
farm
practic
frequenc
dog
studi
popul
would
come
contact
pig
deem
significantli
lower
frequenc
contact
human
addit
although
feed
raw
pork
dog
infrequ
occur
anim
norovirus
extrem
unlik
found
commerci
pet
food
due
unit
kingdom
manufactur
process
regul
initi
serosurvey
demonstr
dog
like
seroposit
gii
hunov
strain
gi
strain
line
find
recent
european
studi
explor
hunovposit
sampl
enter
second
round
elisa
vlp
seven
individu
genotyp
show
highest
seropreval
strain
remark
common
genotyp
infect
human
worldwid
also
correl
report
identifi
hunov
stool
four
dog
hunov
detect
qpcr
stool
dog
stool
dog
comparison
canin
serum
sampl
two
time
period
allow
analysi
chang
preval
antihunov
antibodi
time
although
two
studi
popul
directli
compar
earlier
group
rehom
kennel
later
veterinari
referr
hospit
rang
hunov
strain
studi
limit
shown
proport
dog
seroposit
hunov
increas
period
preval
hunov
human
unit
kingdom
increas
similar
time
period
approxim
possibl
specul
rise
hunov
seropreval
dog
onward
reflect
increas
level
infect
human
popul
overal
studi
support
hypothesi
dog
becom
infect
hunov
howev
mani
question
still
outstand
first
unknown
whether
hunov
infect
potenti
caus
clinic
diseas
dog
answer
definit
experiment
studi
requir
second
assum
dog
becom
infect
hunov
unknown
whether
dog
shed
viru
stool
suffici
quantiti
infect
human
estim
hunov
particl
may
suffici
caus
infect
human
like
low
level
shed
infecti
howev
differ
physiolog
canin
human
gastrointestin
tract
eg
ph
mean
possibl
particl
infect
vari
speci
third
unansw
question
whether
dog
play
signific
role
epidemiolog
certain
hunov
outbreak
major
hunov
outbreak
occur
place
dog
commonli
found
eg
outbreak
cruis
ship
hospit
role
dog
perpetu
outbreak
commun
rule
final
question
whether
potenti
dog
coinfect
cnv
hunov
simultan
also
concern
cnv
may
zoonot
base
serolog
receptor
studi
henc
cnvhunov
coinfect
may
also
possibl
human
coinfect
occur
would
theoret
risk
recombin
viru
strain
lead
gener
novel
noroviru
may
alter
virul
canin
human
host
ongo
surveil
recombin
deem
import
summari
wherea
hunov
infect
dog
shown
theoret
possibl
risk
caus
signific
clinic
diseas
dog
believ
low
potenti
hunov
infect
transmit
dog
owner
yet
establish
though
recommend
sensibl
hygien
precaut
taken
around
pet
especi
gastroenter
either
human
dog
present
household
